Skip to content
This GLP
Updated September 2026Both pages agree

Obu Health review

The homepage card and the product tile print the same figure, which several sellers here cannot manage.

The verdict

Obu Health publishes starting figures of $190 a month for compounded semaglutide and $239 for tirzepatide, read August 2026. The homepage card and the product tile agree on both.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
From
$190/mo
Prescription
Required
Compounded
Yes — not FDA-approved

Obu Health sells both molecules by injection. Two figures are published. Both use starting-from wording.

  1. Who writes the prescription, and what do they see?

    A prescription precedes shipping. The pages state prices. The clinician is not described and the intake is not documented.

    Agreement between two pages is a low bar and several sellers do not clear it. Obu does. What it does not do is say what raises the figure.

  2. What happens when the dose goes up?

    Nothing is published about dose. Starting from leaves the ceiling unstated. The floor is at least consistent across the site.

  3. What the price includes

    Six months at $190 is $1,140 and tirzepatide at $239 is $1,434, both at the floor. What a higher dose costs is not published. Ask before ordering.

  4. What it claims, and what it cites

    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.

Where it holds up, and where it does not

  • Strength: Card and tile print the same figure
  • Strength: Both molecules carry a price
  • Strength: No fees described beside either
  • Limitation: Both figures are a floor
  • Limitation: No milligram dose stated
  • Limitation: No state coverage list is recorded
  • Limitation: No compounding pharmacy is named

What the evidence says about this kind of treatment

The assessment above is about Obu Health. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader who values a site that agrees with itself.
Wrong for
A reader who needs a settled figure at their dose.

How Obu Health compares

SellerWho it suitsGo
NuDay RxReaders wanting an oral semaglutide at the injection priceSee NuDay Rx
Open Water RxReaders who will keep a record of the code and what was promised with itSee Open Water Rx
PepHaūsReaders who will commit a quarter for a modest savingSee PepHaūs
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Rex MDSesame CareSomira HealthSprout HealthStackMDSumbare Wellness

Sponsored alternative

Synergy Rx

A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.

Check Synergy Rx availability →

Frequently asked

Is $190 a rate?
It is a starting figure. What raises it is not published.
Do the two pages agree?
Yes. The homepage card and the product tile print the same figure on both lines.
What dose does it buy?
No milligram figure is published.
Is Obu Health expensive compared with other GLP-1 telehealth sellers?
Obu Health publishes a starting figure of $190/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Obu Health above the median. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Glenn TorresStandards editor · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from Obu Health’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.